Efavirenz-associated CNS disorders linked to CYP2B6 variant

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2005年 / 1035卷 / 1期
关键词：
Central Nervous System; Randomise Control Trial; Haas; Efavirenz; Trial Group;
D O I：
10.2165/00128415-200510350-00009
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5 / 5
相关论文
共 50 条
  • [1] CYP2B6 GENETIC VARIATION AND EFAVIRENZ AUTOINDUCTION INFLUENCES CYP2B6 A ACTIVITY AND EFAVIRENZ EXPOSURE IN HEALTHY VOLUNTEERS
    Metzger, I. F.
    Lu, J. B.
    Kreutz, Y.
    Thong, N.
    Flockhart, D. A.
    Desta, Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S80 - S80
  • [2] CYP2B6 polymorphisms and nevirapine and efavirenz DILI
    Reactions Weekly, 2024, 2037 (1) : 4 - 4
  • [3] Crystal Structure of CYP2B6 in Complex with an Efavirenz Analog
    Shah, Manish B.
    Zhang, Qinghai
    Halpert, James R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (04)
  • [4] Efavirenz intoxication due to a new CYP2B6 constellation
    Anagnostopoulos, Alexia
    Rotger, Margalida
    Aouri, Manel
    Kuster, Stefan P.
    Telenti, Amalio
    Decosterd, Laurent A.
    Guenthard, Huldrych F.
    ANTIVIRAL THERAPY, 2013, 18 (05) : 739 - 743
  • [5] Prenatal efavirenz exposure is independently associated with maternal, but not fetal CYP2B6 genotype
    Eniayewu, Oluwasegun
    Akinloye, Abdulafeez
    Shenkoya, Babajide
    Azuka, Uche
    Bolaji, Oluseye
    Adejuyigbe, Ebunoluwa
    Owen, Andrew
    Olagunju, Adeniyi
    PHARMACOGENETICS AND GENOMICS, 2024, 34 (08): : 253 - 260
  • [6] Effects of the CYP2B6*6 Allele on Catalytic Properties and Inhibition of CYP2B6 In Vitro: Implication for the Mechanism of Reduced Efavirenz Metabolism and Other CYP2B6 Substrates In Vivo
    Xu, Cong
    Ogburn, Evan T.
    Guo, Yingying
    Desta, Zeruesenay
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (04) : 717 - 725
  • [7] Efavirenz Metabolism: Influence of Polymorphic CYP2B6 Variants and Stereochemistry
    Wang, Pan-Fen
    Neiner, Alicia
    Kharasch, Evan D.
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (10) : 1195 - 1205
  • [8] Activity Variations of CYP2B6 Determine the Metabolic Stratification of Efavirenz
    Li, Xin-yue
    Liu, Qian
    Xu, Xiao-yu
    Wang, Jing
    Zhong, Yun-shan
    Jin, Le-hao
    Yuan, Jing
    Qian, Jian-chang
    Zhang, Xiao-dan
    CHEMICAL RESEARCH IN TOXICOLOGY, 2024, 37 (11) : 1867 - 1875
  • [9] Efavirenz and CYP2B6 polymorphism:: Implications for drug toxicity and resistance
    Nolan, D
    Phillips, E
    Mallal, S
    CLINICAL INFECTIOUS DISEASES, 2006, 42 (03) : 408 - 410
  • [10] Pharmacokinetics of Plasma Efavirenz and CYP2B6 Polymorphism in Southern Chinese
    To, Kin Wang
    Liu, Shui Teng
    Cheung, Siu Wai
    Chan, D. Pui Chung
    Chan, R. Chiu Yeung
    Lee, Shui Shan
    THERAPEUTIC DRUG MONITORING, 2009, 31 (04) : 527 - 530
12345